Arcadia Biosciences
RKDA
RKDA
22 hedge funds and large institutions have $1.71M invested in Arcadia Biosciences in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less capital invested
Capital invested by funds: $2.69M → $1.71M (-$978K)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
22
Holding in Top 10
–
Calls
$53K
Puts
$36K
Top Buyers
| 1 | +$59.5K | |
| 2 | +$29K | |
| 3 | +$26.5K | |
| 4 |
SG
StoneX Group
New York
|
+$15.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.6K |
Top Sellers
| 1 | -$122K | |
| 2 | -$80.8K | |
| 3 | -$51K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$49K |
| 5 |
BlackRock
New York
|
-$31.4K |